Kamada Ltd.
KMDANASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 16, 2026 close
- Market cap
- $453.26M
- P/E (TTM)
- 20.30
- Forward P/E
- 10.86
- Dividend yield
- 5.36%
- 52-week range
- $6.55$9.35
- Volume (live)
- -
- Avg. volume (3M)
- 116.98K
Kamada (KMDA) Stock Price & Financial Analysis
Kamada Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $7.73 - $7.91 |
|---|---|
| 52-Week High | $9.35 |
| 52-Week Low | $6.55 |
| Open | $7.83 |
| Volume (last close) | 41.60K |
| Average Volume (3M) | 116.98K |
| Revenue (TTM) | 192.77M |
|---|---|
| Net Income (TTM) | 22.33M |
| Free Cash Flow (TTM) | 26.48M |
| EPS (TTM) | $0.38 |
| Profit Margin | 11.58% |
| Operating Margin | 14.47% |
| Return on Equity (ROE) | 8.28% |
| Debt to Equity | 0.04 |
| Annual Dividend | $0.42 |
|---|---|
| Dividend Yield | 5.36% |
| Payout Ratio | 111.67% |
| Last Dividend Ex-Date | Aug 27, 2026 |
| Market Cap | 453.26M |
|---|---|
| Shares Outstanding | 57.89M |
| P/E Ratio (TTM) | 20.30 |
| Forward P/E | 10.86 |
| Price to Sales (P/S) | 2.35 |
| Price to Book (P/B) | 1.68 |
| EV/EBITDA | 10.71 |
| 50-Day MA | $8.10 |
|---|---|
| 200-Day MA | $8.01 |
| 1-Year Change | +16.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Kamada at a Glance
As of the Oct 16, 2026 close, Kamada (KMDA) has a market capitalization of $453.26M. The stock trades at 20.3× trailing earnings, 10.9× forward earnings and 2.4× sales. Over the trailing twelve months it earned $22.33M on revenue of $192.77M (a 11.6% profit margin) and generated $26.48M of free cash flow. Revenue grew 13.2% year over year.
As of its latest reported balance sheet, it holds $29.47M in cash and securities against $11.79M of debt, a net cash position of $17.69M.
Kamada pays a annual dividend totaling $0.42 per share a year, a 5.36% yield at the Oct 16, 2026 close, with a 112% payout ratio.
The share price is up 16.0% over the past year. At $7.76 (the Oct 16, 2026 close) it sits within its 52-week range of $6.55 to $9.35, below its 200-day moving average of $8.01.
Based on 1 professional analyst rating from the past 90 days, the consensus is Buy.
Frequently Asked Questions About Kamada
What is the current stock price for KMDA?
As of the Oct 16, 2026 close, KMDA stock trades at $7.76. The 52-week range is $6.55–$9.35, with a day range of $7.73–$7.91.
What is the P/E ratio for KMDA?
As of the Oct 16, 2026 close, Kamada's trailing twelve-month (TTM) P/E ratio is 20.3, meaning investors pay $20.3 for every $1 of annual earnings. The forward P/E is 10.9, reflecting analyst expectations for future earnings. Kamada operates in the Healthcare sector.
Does KMDA pay dividends?
Yes, Kamada pays a 5.36% annual dividend yield as of the Oct 16, 2026 close ($0.42 per share a year). The trailing twelve-month payout ratio is 111.7%. The most recent ex-dividend date was August 27, 2026.
What do analysts recommend for KMDA?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for KMDA is Buy.
What is the market cap of KMDA?
As of the Oct 16, 2026 close, Kamada's market capitalization is $449.2M, classifying it as a small-cap company. Kamada operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.